Gilead Group focuses on providing strategic oversight, financial resources, and operational support to a mix of organic start-ups and acquisitions. The firm primarily operates in the States of Missouri and Indiana, investing in fast-growing businesses with the goal of long-term growth and profitability. Their typical investment rounds include Series B and Series C, with investments ranging from $5 million to $60 million.
Notable portfolio companies include Agilis Systems, which has raised $5 million, and Hookipa Pharma, which has raised $60 million. Gilead Group's key partners bring extensive experience and a hands-on approach to nurturing businesses. Their investment philosophy emphasizes sustainable growth and profitability, offering unique value-add services such as strategic oversight and operational support to ensure the success of their portfolio companies.